Skip to main content
Premium Trial:

Request an Annual Quote

Start-up Pharmacogenomics Firm Gentris Locks in $1.5M in Private Equity

NEW YORK, March 19 - Start-up pharmacogenomics company Gentris on Tuesday said it has secured $1.5 million in private-equity financing.

 

Research Triangle Ventures and Exelixis led the round, which also included angel investors.

 

Gentris said it plans to use the cash to "up-fit" its lab and hire "key senior staff."

 

The company, founded last year, aims to build a "turnkey pharmacogenomic solution of products and services." It is based in Research Triangle Park, NC.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.